Literature DB >> 18974133

Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment.

Masahisa Jinushi1, Yukoh Nakazaki, Daniel R Carrasco, Dobrin Draganov, Nicholas Souders, Matthew Johnson, Martin C Mihm, Glenn Dranoff.   

Abstract

The pathogenesis of malignant melanoma involves the interplay of tumor cells with normal host elements, but the underlying mechanisms are incompletely understood. Here, we show that milk fat globule EGF-8 (MFG-E8), a secreted protein expressed at high levels in the vertical growth phase of melanoma, promotes disease progression through coordinated alpha(v)beta(3) integrin signaling in the tumor microenvironment. In a murine model of melanoma, MFG-E8 enhanced tumorigenicity and metastatic capacity through Akt-dependent and Twist-dependent pathways. MFG-E8 augmented melanoma cell resistance to apoptosis, triggered an epithelial-to-mesenchymal transition (EMT), and stimulated invasion and immune suppression. In human melanoma cells, MFG-E8 knockdown attenuated Akt and Twist signaling and thereby compromised tumor cell survival, EMT, and invasive ability. MFG-E8-deficient human melanoma cells also showed increased sensitivity to small molecule inhibitors of insulin-like growth factor I receptor and c-Met. Together, these findings delineate pleiotropic roles for MFG-E8 in the tumor microenvironment and raise the possibility that systemic MFG-E8 blockade might prove therapeutic for melanoma patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974133     DOI: 10.1158/0008-5472.CAN-08-2147

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  Multiple vaccinations: friend or foe.

Authors:  Sarah E Church; Shawn M Jensen; Christopher G Twitty; Keith Bahjat; Hong-Ming Hu; Walter J Urba; Bernard A Fox
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

2.  Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.

Authors:  Zhiliang Wu; Thidarut Boonmars; Isao Nagano; Watcharin Loilome; Puangrat Yongvanit; Narong Khuntikeo; Phuangphaka Sadee Nielsen; Chawalit Paorojkul; Yuzo Takahashi; Yoichi Maekawa
Journal:  Tumour Biol       Date:  2014-03

3.  Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Authors:  Zhiliang Wu; Thidarut Boonmars; Sirintip Boonjaraspinyo; Isao Nagano; Somchai Pinlaor; Anucha Puapairoj; Puangrat Yongvanit; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2011-03-05       Impact factor: 2.289

4.  MFG-E8 expression for progression of oral squamous cell carcinoma and for self-clearance of apoptotic cells.

Authors:  Manabu Yamazaki; Satoshi Maruyama; Tatsuya Abé; Ahmed Essa; Hamzah Babkair; Jun Cheng; Takashi Saku
Journal:  Lab Invest       Date:  2014-09-29       Impact factor: 5.662

5.  Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial.

Authors:  Craig L Slingluff; Gina R Petroni; Walter C Olson; Mark E Smolkin; Merrick I Ross; Naomi B Haas; William W Grosh; Marc E Boisvert; John M Kirkwood; Kimberly A Chianese-Bullock
Journal:  Clin Cancer Res       Date:  2009-11-10       Impact factor: 12.531

6.  MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages.

Authors:  Kazuya Yamada; Akihiko Uchiyama; Akihito Uehara; Buddhini Perera; Sachiko Ogino; Yoko Yokoyama; Yuko Takeuchi; Mark C Udey; Osamu Ishikawa; Sei-Ichiro Motegi
Journal:  Cancer Res       Date:  2016-05-17       Impact factor: 12.701

Review 7.  Clearance of apoptotic cells: implications in health and disease.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  J Cell Biol       Date:  2010-06-28       Impact factor: 10.539

8.  Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.

Authors:  Masahisa Jinushi; Marimo Sato; Akira Kanamoto; Akihiko Itoh; Shigenori Nagai; Shigeo Koyasu; Glenn Dranoff; Hideaki Tahara
Journal:  J Exp Med       Date:  2009-05-11       Impact factor: 14.307

9.  Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.

Authors:  Hideaki Tahara; Marimo Sato; Magdalena Thurin; Ena Wang; Lisa H Butterfield; Mary L Disis; Bernard A Fox; Peter P Lee; Samir N Khleif; Jon M Wigginton; Stefan Ambs; Yasunori Akutsu; Damien Chaussabel; Yuichiro Doki; Oleg Eremin; Wolf Hervé Fridman; Yoshihiko Hirohashi; Kohzoh Imai; James Jacobson; Masahisa Jinushi; Akira Kanamoto; Mohammed Kashani-Sabet; Kazunori Kato; Yutaka Kawakami; John M Kirkwood; Thomas O Kleen; Paul V Lehmann; Lance Liotta; Michael T Lotze; Michele Maio; Anatoli Malyguine; Giuseppe Masucci; Hisahiro Matsubara; Shawmarie Mayrand-Chung; Kiminori Nakamura; Hiroyoshi Nishikawa; A Karolina Palucka; Emanuel F Petricoin; Zoltan Pos; Antoni Ribas; Licia Rivoltini; Noriyuki Sato; Hiroshi Shiku; Craig L Slingluff; Howard Streicher; David F Stroncek; Hiroya Takeuchi; Minoru Toyota; Hisashi Wada; Xifeng Wu; Julia Wulfkuhle; Tomonori Yaguchi; Benjamin Zeskind; Yingdong Zhao; Mai-Britt Zocca; Francesco M Marincola
Journal:  J Transl Med       Date:  2009-06-17       Impact factor: 5.531

10.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.